These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 19549266

  • 1. Review article: the current and evolving treatment of colonic diverticular disease.
    Tursi A, Papagrigoriadis S.
    Aliment Pharmacol Ther; 2009 Sep 15; 30(6):532-46. PubMed ID: 19549266
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
    Strate LL, Modi R, Cohen E, Spiegel BM.
    Am J Gastroenterol; 2012 Oct 15; 107(10):1486-93. PubMed ID: 22777341
    [Abstract] [Full Text] [Related]

  • 4. Colonic diverticular disease. Treatment and prevention.
    Gargallo Puyuelo CJ, Sopeña F, Lanas Arbeloa A.
    Gastroenterol Hepatol; 2015 Dec 15; 38(10):590-9. PubMed ID: 25979437
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Diverticulitis: new insights on the traditional point of view.
    Moubax K, Urbain D.
    Acta Gastroenterol Belg; 2015 Dec 15; 78(1):38-48. PubMed ID: 26118576
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mesalazine for diverticular disease of the colon--a new role for an old drug.
    Tursi A.
    Expert Opin Pharmacother; 2005 Jan 15; 6(1):69-74. PubMed ID: 15709884
    [Abstract] [Full Text] [Related]

  • 10. Pathophysiology and Therapeutic Strategies for Symptomatic Uncomplicated Diverticular Disease of the Colon.
    Scaioli E, Colecchia A, Marasco G, Schiumerini R, Festi D.
    Dig Dis Sci; 2016 Mar 15; 61(3):673-83. PubMed ID: 26458921
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trials.
    Raskin JB, Kamm MA, Jamal MM, Márquez J, Melzer E, Schoen RE, Szalóki T, Barrett K, Streck P.
    Gastroenterology; 2014 Oct 15; 147(4):793-802. PubMed ID: 25038431
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Emerging therapies for diverticular disease of the colon.
    Trivedi CD, Das KM, NDSG.
    J Clin Gastroenterol; 2008 Oct 15; 42(10):1145-51. PubMed ID: 18936655
    [Abstract] [Full Text] [Related]

  • 18. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
    Festi D, Colecchia A.
    Am J Gastroenterol; 2009 Feb 15; 104(2):532. PubMed ID: 19174809
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Rifaximin in the management of colonic diverticular disease.
    Latella G, Scarpignato C.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 15; 3(6):585-98. PubMed ID: 19929580
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.